These findings highlight the possible role of FGF21 as a biomarker and a therapeutic tool in mice with sepsis and an inflammatory state, leading us to explore its role in humans with sepsis and systemic inflammatory response syndrome (SIRS) as compared with healthy subjects. The gene discussed is FGF21; the disease is systemic inflammatory response syndrome.